-
Portage Biotech (PRTG) Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
-
Portage Biotech (PRTG) to Acquire iOx Therapeutics
-
Portage Biotech (PRTG) Receives Nasdaq Non-compliance Letter
-
Portage Biotech (PRTG) Announces 1:20 Reverse Share Split

